Chris Gordon, a principal at Bain Capital LLC, spoke at The Deal's Healthcare Dealmaking Symposium about Bain Capital's acquisition of Quintiles Transnational Corp., a clinical research service for biotech and pharmaceutical companies. "It has a fundamental growth to make this an interesting deal to us," he stated. -
Maria Woehr
Continue reading below